Stock comparison
Inspire Medical Systems
LeMaitre Vascular
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
INSP
Inspire Medical Systems
Market cap
$1.21B
Sector
Healthcare
LMAT
LeMaitre Vascular
Market cap
$2.32B
Sector
Healthcare
Overall winner
LeMaitre Vascular LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | INSP | LMAT | Winner |
|---|---|---|---|
| Warren Buffett | 50D | 77B | LMAT |
| Benjamin Graham | 37D | 89A | LMAT |
| Philip Fisher | 48D | 81C | LMAT |
| Peter Lynch | 71B | 67B | INSP |
| Joel Greenblatt | 49D | 56D | LMAT |
| Charlie Munger | 32F | 68D | LMAT |
| Terry Smith | 33F | 69D | LMAT |
Side-by-side metrics
| Metric | INSP | LMAT |
|---|---|---|
| Market cap | $1.21B | $2.32B |
| P/E (TTM) | 9.2x | 37.1x |
| EV/EBIT | 22.3x | 36.6x |
| ROIC (TTM) | 6.24% | 9.43% |
| Gross margin | 85.78% | 72.39% |
| Net margin | 14.33% | 24.35% |
| Revenue CAGR 5y | 40.6% | 12.75% |
| EPS CAGR 5y | - | 19.04% |
| Debt / Equity | 0.0x | 0.5x |
| Dividend yield | 0.0% | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
INSP leads on
- Debt / Equity0.0xvs 0.5x+92%
- P/E (TTM)9.2xvs 37.1x+75%
- Revenue CAGR 5y40.6%vs 12.75%+69%
- EV/EBIT22.3xvs 36.6x+39%
LMAT leads on
- Dividend yield0.84%vs 0.0%+100%
- Market cap$2.32Bvs $1.21B+48%
- Net margin24.35%vs 14.33%+41%
- ROIC (TTM)9.43%vs 6.24%+34%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.